A domain-aware symbolic regression framework that discovers closed-form analytical expressions for ln(y), enabling interpretable and transferable solubility modeling across chemically diverse pharmaceutical compounds and demonstrates that domain-aware learning and symbolic discovery can jointly address the dual challenge of predictive robustness under domain shift and model interpretability in supercritical pharmaceutical solubility modeling.
Abstract
Accurate prediction of drug solubility in supercritical CO₂ remains challenging due to the limited generalizability of compound-specific correlations and the black-box nature of most machine learning models. This study proposes a domain-aware symbolic regression framework that discovers closed-form analytical expressions for ln(y), enabling interpretable and transferable solubility modeling across chemically diverse pharmaceutical compounds. A leave-one-drug-out (LODO) validation strategy is employed to rigorously assess extrapolation performance on unseen drug domains across a curated dataset of 196 experimental data points spanning 9 antihypertensive compounds. Under this evaluation, the domain-adversarial neural network (DANN) component of the proposed framework achieved RMSE = 0.33 ± 0.08, MAE = 0.24 ± 0.06, and R² = 0.89 ± 0.05, outperforming standard machine learning baselines including Random Forest, XGBoost, and Multi-Layer Perceptron in cross-domain generalization. The symbolic regression component additionally recovered compact closed-form analytical expressions that accurately represent the full experimental dataset (in-sample expression fit: R² = 0.962, RMSE = 0.031, MAE = 0.024) while remaining physically interpretable and analytically tractable. The combined framework demonstrates that domain-aware learning and symbolic discovery can jointly address the dual challenge of predictive robustness under domain shift and model interpretability in supercritical pharmaceutical solubility modeling.
This study provides a structured and reproducible assessment of the conditions under which descriptor-based ML models can be expected to succeed or fail in DES systems and highlights the importance of rigorous, leakage-aware evaluation in data-driven chemical modeling.
Hakim Faraji, Julio Brito Santana, R. Rodríguez-Ramos et al.· ACS Omega· 0 citations
An integrated interpretable artificial intelligence framework for modeling drug solubility in SC-CO₂ is proposed by combining high-performance gradient boosting algorithms, explainable machine learning, Bayesian optimization, and causal inference.
Wael A. Mahdi, Adel Alhowyan, A. Obaidullah· Scientific Reports· 0 citations
A framework that fine-tunes a general baseline model trained on publicly available data on small, class-specific datasets to retain the baseline’s generalization ability while gaining class-specific accuracy and produce probabilistic outputs that capture uncertainty in the training data is proposed.
C. Barajas, Laura L. Dunphy, Luke C. Mullany et al.· bioRxiv· 0 citations
HGB accurately correlated solubility within the investigated data distribution and retained useful predictive ability for compounds excluded from model training, but external validation and additional molecular descriptors are required before extrapolating the model to chemically distinct pharmaceuticals.
Tested across the MoleculeACE benchmarks, the results indicate that while contrastive losses prevent GNN mode collapse to some extent and drastically improve the property-based separation in the embedding space, their impact on absolute predictive accuracy remains highly dataset dependent.
Akash Surendran, R. Miranda-Quintana· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.